July 24, 2012

An experimental drug under development by Pfizer and a unit of Johnson & Johnson does not appear effective in Alzheimer's disease patients who carry a certain genotype, according to results of a late-stage clinical trial announced by Pfizer on Tuesday.

July 23, 2012

Less than one-third of people take the basic steps necessary to preserve eye sight, according to a Bausch + Lomb global survey released last week.

July 23, 2012

The Centers for Medicare and Medicaid Services on Monday hosted a public meeting to entertain a controversial payment adjustment — called "inherent reasonableness" — in reimbursing for non-mail-order diabetes supplies.

July 23, 2012

The Food and Drug Administration has approved a new use for a Novartis cancer drug.

July 23, 2012

The Food and Drug Administration has approved a new drug for treating multiple myeloma, the agency said Friday.

July 23, 2012

A drug made by Pfizer for treating pain disorders doesn't affect men's reproductive functions, according to a new post-approval clinical study.

July 20, 2012

The Council for Responsible Nutrition announced it is hosting a free webinar on the interaction between dietary supplements and pharmaceutical drugs via the professional networking website Pharmacist Society, an online community created by Skipta and sponsored by The Drug Store News Group, and Generation NP, a website that serves nurse practitioners.

July 20, 2012

A division of Nestle has bought a stake in a Colorado-based drug maker focused on treatments for neurodegenerative diseases.

July 19, 2012

Roche on Wednesday announced that it has received clearance from the Food and Drug Administration for its Accu-Chek Combo system for insulin pump therapy.

July 18, 2012

The Food and Drug Administration has approved a new weight-loss drug made by Vivus, the agency said.

July 16, 2012

Prescription drug counterfeiting got significant attention in March 2011 when CBS News’ “60 Minutes” reported on the problem, including a tour of a drug counterfeiting operation.


July 16, 2012

The Food and Drug Administration has accepted a regulatory application for an opioid painkiller made by Zogenix, the company said Monday.

July 16, 2012

The Food and Drug Administration has approved a drug used to treat HIV for reducing the risk of HIV infection, the agency said Monday.

July 16, 2012

British drug maker GlaxoSmithKline will acquire development partner Human Genome Sciences for $3.6 billion, GSK said Monday.

July 16, 2012

Several policy-makers and companies have sought ways to confront the problem of prescription drug abuse. Last month, New York Gov. Andrew Cuomo announced a plan — calling it the first in the country — to create an all-
electronic registry that would enable doctors, pharmacists and law enforcement to track controlled substances to prevent excessive prescription and refill requests.

July 16, 2012

Sanofi Pasteur has begun shipping the first lots of its influenza vaccine for the 2012-2013 season.

July 16, 2012

UCB has launched a new drug for treating Parkinson's disease and restless legs syndrome, the company said Monday.

July 13, 2012

The Food and Drug Administration has approved a generic contraceptive made by Watson Pharmaceuticals, the drug maker said Friday.

July 13, 2012

GlaxoSmithKline and Theravance submitted a regulatory application to the Food and Drug Administration for their chronic obstructive pulmonary disease treatment.

July 13, 2012

Nearly 200 drugs for mental illnesses are under clinical development or under review by the Food and Drug Administration, the largest lobbying group for the drug industry said Thursday.

July 12, 2012

A clinical trial of a drug for schizophrenia did not yield the desired results, the drug's developer said.

July 10, 2012

President Barack Obama signed into law Monday what some called a "historic" reauthorization of the Prescription Drug User Fee Act.

July 9, 2012

The Food and Drug Administration has approved a drug made by Eli Lilly and Bristol-Myers Squibb for treating a form of colorectal cancer, the two companies said.

July 9, 2012

The Food and Drug Administration has given priority review to a drug as a treatment for blood-clot disorders, the manufacturer said Monday.